Published in Eur J Clin Invest on January 01, 2007
Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci (2010) 3.72
Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2010) 2.28
Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res (2011) 1.42
Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol (2010) 1.01
Intermediate filament cytoskeleton of the liver in health and disease. Histochem Cell Biol (2008) 0.99
Serum levels of keratin-18 fragments [tissue polypeptide-specific antigen (TPS)] are correlated with hepatocyte apoptosis in alcoholic hepatitis. Dig Dis Sci (2008) 0.82
Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver. Hepatology (2016) 0.80
From bed to bench: which attitude towards the laboratory liver tests should health care practitioners strike? World J Gastroenterol (2007) 0.75
Nonalcoholic fatty liver disease: Diagnostic biomarkers. World J Gastrointest Pathophysiol (2017) 0.75
Elevated serum aminotransferase activity as an early manifestation of gluten-sensitive enteropathy. J Pediatr (1993) 2.88
The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis (2006) 2.83
Iron deficiency anaemia and febrile convulsions: case-control study in children under 2 years. BMJ (1996) 1.81
Genetic modulation of oral anticoagulation with warfarin. Thromb Haemost (2000) 1.67
Limb body wall complex: a critical review and a nosological proposal. Am J Med Genet (1993) 1.64
Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest (2000) 1.60
Mortality and causes of death in Italian persons with haemophilia, 1990-2007. Haemophilia (2010) 1.59
Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers. J Thromb Haemost (2012) 1.57
An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. Neurology (2007) 1.56
Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol (1998) 1.49
Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex. Blood (1983) 1.44
Low daily dosage of interferon for 1 year after HCV-related end-therapy response. A randomized-controlled study. Liver Int (2003) 1.39
Double-stranded DNA can be translocated across a planar membrane containing purified mitochondrial porin. FASEB J (1998) 1.33
Effects of secondary prophylaxis started in adolescent and adult haemophiliacs. Haemophilia (2008) 1.28
A novel type of resistant bacteria induced by gentamicin. Trans N Y Acad Sci (1974) 1.27
Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years. J Viral Hepat (2006) 1.26
Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler Thromb Vasc Biol (1999) 1.25
Increased risk for venous thrombosis in carriers of the prothrombin G-->A20210 gene variant. Ann Intern Med (1998) 1.20
Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis. Am J Med (1985) 1.15
The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost (1998) 1.13
Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol (2001) 1.12
West syndrome associated with 14q12 duplications harboring FOXG1. Neurology (2011) 1.12
Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost (1997) 1.11
Association between hepatitis C and hepatitis E viruses in southern Italy. Lancet (1994) 1.10
Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism. Thromb Haemost (1999) 1.09
Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe. Arterioscler Thromb Vasc Biol (2002) 1.08
DNA translocation across planar bilayers containing Bacillus subtilis ion channels. J Biol Chem (1997) 1.07
Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost (1997) 1.05
Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica (2001) 1.03
Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost (2000) 1.02
How Drosophila males make eggs: it is elemental. Proc Biol Sci (2001) 1.02
The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol (1998) 1.02
Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study. Arterioscler Thromb Vasc Biol (2007) 1.02
The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events. Thromb Haemost (2000) 1.01
Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease. Ann Hematol (2001) 1.00
The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study. J Thromb Haemost (2003) 1.00
PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants. Arterioscler Thromb Vasc Biol (1998) 0.99
Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors. J Thromb Haemost (2009) 0.98
Oxidative stress and platelet activation in homozygous homocystinuria. Circulation (2001) 0.98
Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. J Clin Invest (1985) 0.97
Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy. Ann Nutr Metab (2005) 0.97
Aagenaes's syndrome in an Italian child. Acta Paediatr Scand (1984) 0.97
Cost of care of haemophilia with inhibitors. Haemophilia (2009) 0.96
Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism. Thromb Res (2011) 0.95
Unfavourable outcome of Hashimoto encephalopathy due to status epilepticus. One autopsy case. J Neurol (2005) 0.94
Prostaglandins as inhibitors of human platelet aggregation. Br J Haematol (1979) 0.94
An alternative method for PAI-1 promoter polymorphism (4G/5G) typing. Thromb Haemost (1997) 0.93
The use of antithrombotic drugs in older people. Minerva Med (2002) 0.92
Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease. J Biol Regul Homeost Agents (2011) 0.91
Diabetes, vascular complications and antiplatelet therapy: open problems. Acta Diabetol (2008) 0.91
Monitoring the entry of new platelets into the circulation after ingestion of aspirin. Blood (1983) 0.90
Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen. J Lab Clin Med (1986) 0.89
A transplantable mouse lymphoma with unusual azurophilic granules. Am J Pathol (1973) 0.88
Snorting benzodiazepines. Am J Drug Alcohol Abuse (1991) 0.88
[Basophil count of the newborn is not useful in prediction of allergic diseases]. Pediatr Med Chir (1996) 0.88
Ultrastructural changes in lymphoma cells treated with hematoporphyrin and light. Am J Pathol (1980) 0.88
A clinical-morphological study on cholestatic presentation of nonalcoholic fatty liver disease. Dig Dis Sci (2005) 0.88
Life saving cyclophosphamide treatment in a girl with giant cell hepatitis and autoimmune haemolytic anaemia: case report and up-to-date on therapeutical options. Dig Liver Dis (2005) 0.88
Magnetic resonance imaging and ultrasound evaluation of "healthy" joints in young subjects with severe haemophilia A. Haemophilia (2013) 0.87
Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol (1999) 0.87
Anticardiolipin antibodies in patients with liver disease. Am J Gastroenterol (1999) 0.87
Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes. Arterioscler Thromb Vasc Biol (1997) 0.87
Laparoscopy-guided biopsy in diagnosis of liver disorders in children. Liver (1997) 0.86
Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection. Pediatr Infect Dis J (1996) 0.86
Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke. Arterioscler Thromb Vasc Biol (1996) 0.86
Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas. J Pathol (2000) 0.86
Diffuse emphysema as a result of nonobstructive interstitial pulmonary disease. Am Rev Respir Dis (1967) 0.86
Citizens and family doctors facing awareness and management of traditional cardiovascular risk factors: results from the Global Cardiovascular Risk Reduction Project (Help Your Heart Stay Young Study). Nutr Metab Cardiovasc Dis (2003) 0.86
Iron deficiency in childhood and adolescence: retrospective review. Hematology (2006) 0.86
Early-onset absence epilepsy: SLC2A1 gene analysis and treatment evolution. Eur J Neurol (2012) 0.85
Familial temporal lobe epilepsy with psychic auras associated with a novel LGI1 mutation. Neurology (2011) 0.85
Circadian rhythmicity of plasma amino acid variations in healthy subjects. Recenti Prog Med (1989) 0.85
Autologous bone marrow cell therapy for peripheral arterial disease. Stem Cells Cloning (2012) 0.85
[Giardia duodenalis infections in pediatrics: our series]. Infez Med (1996) 0.85
Breast feeding and acute lower respiratory infection. Acta Paediatr (1994) 0.84
Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies. Haemophilia (2012) 0.84
A spectrum of histopathologic findings in autoimmune liver disease. Am J Clin Pathol (2000) 0.84
Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study. Atherosclerosis (2004) 0.84
Retinal vein occlusion and inherited conditions predisposing to thrombophilia. Thromb Haemost (1998) 0.84
Potentially malignant and malignant lesions of the lip. Role of silver staining nucleolar organizer regions, proliferating cell nuclear antigen, p53, and c-myc in differentiation and prognosis. J Oral Pathol Med (1999) 0.84
Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension. Am J Cardiol (1999) 0.84
Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke. Arterioscler Thromb (1994) 0.84
The effect of the interleukin-6 c/g-174 polymorphism and circulating interleukin-6 on fibrinogen plasma levels. Haematologica (2001) 0.83
Desmopressin in inherited disorders of platelet function. Haemophilia (2008) 0.83
Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors. Haemophilia (2011) 0.83
Relations of left ventricular mass and systolic function to endothelial function and coronary flow reserve in healthy, new discovered hypertensive subjects. J Hum Hypertens (2005) 0.83
Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria. Thromb Haemost (1999) 0.83
Low-dose methotrexate treatment for interstitial pregnancy. A case report. J Reprod Med (2000) 0.82
Coronary artery disease, cerebral non-fatal ischemic stroke in retinal vein occlusion: an 8-yr follow-up. Nutr Metab Cardiovasc Dis (2010) 0.82
Compound heterozygosity (554-589 del, C515-T transition) in the platelet glycoprotein Ib alpha gene in a patient with a severe bleeding tendency. Thromb Haemost (1999) 0.82
Pseudolymphoma with mycosis fungoides manifestations, hyperresponsiveness to diphenylhydantoin, and lymphocyte disregulation. Cancer (1982) 0.82
Cardiac troponin I in acute coronary ischemic syndromes. Epidemiological and clinical correlates. Int J Cardiol (2001) 0.82